H2BC18 and endometrium adenocarcinoma: In addition, H2BC18 had a hypermethylated status in germ cell tumors (GCT), cervical squamous cell carcinoma and endometrial adenocarcinoma (CSEC), and uterine carcinosarcoma (UCS) (Figure 12C).